BACKGROUND: Asthma and chronic obstructive pulmonary disease (COPD) have considerable potential for inequities in diagnosis and treatment, thereby affecting vulnerable groups. OBJECTIVE: To evaluate differences in asthma and COPD prevalence between adult Aboriginal and non-Aboriginal populations. METHODS: MEDLINE, Embase, specialized databases and the grey literature up to October 2011 were searched to identify epidemiological studies comparing asthma and COPD prevalence between Aboriginal and non-Aboriginal adult populations. Prevalence ORs (PORs) and 95% CIs were calculated in a random-effects meta-analysis. RESULTS: Of 132 studies, eight contained relevant data. Aboriginal populations included Native Americans, Canadian Aboriginals, Australian Aboriginals and New Zealand Maori. Overall, Aboriginals were more likely to report having asthma than non-Aboriginals (POR 1.41 [95% CI 1.23 to 1.60]), particularly among Canadian Aboriginals (POR 1.80 [95% CI 1.68 to 1.93]), Native Americans (POR 1.41 [95% CI 1.13 to 1.76]) and Maori (POR 1.64 [95% CI 1.40 to 1.91]). Australian Aboriginals were less likely to report asthma (POR 0.49 [95% CI 0.28 to 0.86]). Sex differences in asthma prevalence between Aboriginals and their non-Aboriginal counterparts were not identified. One study compared COPD prevalence between Native and non-Native Americans, with similar rates in both groups (POR 1.08 [95% CI 0.81 to 1.44]). CONCLUSIONS: Differences in asthma prevalence between Aboriginal and non-Aboriginal populations exist in a variety of countries. Studies comparing COPD prevalence between Aboriginal and non-Aboriginal populations are scarce. Further investigation is needed to identify and account for factors associated with respiratory health inequalities among Aboriginal peoples.
BACKGROUND:Asthma and chronic obstructive pulmonary disease (COPD) have considerable potential for inequities in diagnosis and treatment, thereby affecting vulnerable groups. OBJECTIVE: To evaluate differences in asthma and COPD prevalence between adult Aboriginal and non-Aboriginal populations. METHODS: MEDLINE, Embase, specialized databases and the grey literature up to October 2011 were searched to identify epidemiological studies comparing asthma and COPD prevalence between Aboriginal and non-Aboriginal adult populations. Prevalence ORs (PORs) and 95% CIs were calculated in a random-effects meta-analysis. RESULTS: Of 132 studies, eight contained relevant data. Aboriginal populations included Native Americans, Canadian Aboriginals, Australian Aboriginals and New Zealand Maori. Overall, Aboriginals were more likely to report having asthma than non-Aboriginals (POR 1.41 [95% CI 1.23 to 1.60]), particularly among Canadian Aboriginals (POR 1.80 [95% CI 1.68 to 1.93]), Native Americans (POR 1.41 [95% CI 1.13 to 1.76]) and Maori (POR 1.64 [95% CI 1.40 to 1.91]). Australian Aboriginals were less likely to report asthma (POR 0.49 [95% CI 0.28 to 0.86]). Sex differences in asthma prevalence between Aboriginals and their non-Aboriginal counterparts were not identified. One study compared COPD prevalence between Native and non-Native Americans, with similar rates in both groups (POR 1.08 [95% CI 0.81 to 1.44]). CONCLUSIONS: Differences in asthma prevalence between Aboriginal and non-Aboriginal populations exist in a variety of countries. Studies comparing COPD prevalence between Aboriginal and non-Aboriginal populations are scarce. Further investigation is needed to identify and account for factors associated with respiratory health inequalities among Aboriginal peoples.
Authors: K R Chapman; D M Mannino; J B Soriano; P A Vermeire; A S Buist; M J Thun; C Connell; A Jemal; T A Lee; M Miravitlles; S Aldington; R Beasley Journal: Eur Respir J Date: 2006-01 Impact factor: 16.671
Authors: Shawn D Aaron; Katherine L Vandemheen; Louis-Philippe Boulet; R Andrew McIvor; J Mark Fitzgerald; Paul Hernandez; Catherine Lemiere; Sat Sharma; Stephen K Field; Gonzalo G Alvarez; Robert E Dales; Steve Doucette; Dean Fergusson Journal: CMAJ Date: 2008-11-18 Impact factor: 8.262
Authors: Klaus F Rabe; Suzanne Hurd; Antonio Anzueto; Peter J Barnes; Sonia A Buist; Peter Calverley; Yoshinosuke Fukuchi; Christine Jenkins; Roberto Rodriguez-Roisin; Chris van Weel; Jan Zielinski Journal: Am J Respir Crit Care Med Date: 2007-05-16 Impact factor: 21.405
Authors: Andrea S Gershon; Saba Khan; Julie Klein-Geltink; Drew Wilton; Teresa To; Eric J Crighton; Lisa Pigeau; Jo Macquarrie; Yvon Allard; Storm J Russell; David A Henry Journal: PLoS One Date: 2014-04-23 Impact factor: 3.240
Authors: Maria B Ospina; Don Voaklander; Ambikaipakan Senthilselvan; Michael K Stickland; Malcolm King; Andrew W Harris; Brian H Rowe Journal: PLoS One Date: 2015-04-13 Impact factor: 3.240
Authors: Maria B Ospina; Donald C Voaklander; Michael K Stickland; Malcolm King; Ambikaipakan Senthilselvan; Brian H Rowe Journal: Can Respir J Date: 2017-11-05 Impact factor: 2.409
Authors: Janwillem W H Kocks; Henry Chrystyn; Job van der Palen; Mike Thomas; Louisa Yates; Sarah H Landis; Maurice T Driessen; Mugdha Gokhale; Raj Sharma; Mathieu Molimard Journal: NPJ Prim Care Respir Med Date: 2018-11-16 Impact factor: 2.871
Authors: Subash S Heraganahally; Sanjiwika L Wasgewatta; Kelly McNamara; Carla C Eisemberg; Richard C Budd; Sumit Mehra; Dimitar Sajkov Journal: Int J Chron Obstruct Pulmon Dis Date: 2019-09-26
Authors: Matthieu Storme; Alexandre Semionov; Deborah Assayag; Michael Lefson; Darlene Kitty; David Dannenbaum; Jill Torrie; Pierre Lejeune; Elizabeth Robinson; Faiz Ahmad Khan Journal: PLoS One Date: 2017-09-08 Impact factor: 3.240
Authors: Helena Crisford; Elizabeth Sapey; Geraint B Rogers; Steven Taylor; Prasad Nagakumar; Ravi Lokwani; Jodie L Simpson Journal: Thorax Date: 2021-02-25 Impact factor: 9.139